Companion Diagnostics for Oncology Market Size, Share and Forecast to 2033

Research Methodology – Companion Diagnostics for Oncology Market

At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Companion Diagnostics for Oncology Market comprises the following key stages:

Market Indicator & Macro-Factor Analysis

Our baseline thesis for the Companion Diagnostics for Oncology Market is developed by integrating key market indicators and macroeconomic variables. These include:

1 Factors considered while calculating market size and share

Prevalence and incidence rates of various types of cancers globally
Number of oncology drug development projects undergoing clinical trials
Trends in companion diagnostic product launches
Government policies and regulations relating to companion diagnostics and oncology
Investments and funding in oncology research and development
Healthcare infrastructure and usage rates of diagnostic tests for cancer
Partnerships, mergers and acquisitions among pharmaceutical companies and diagnostic manufacturers
Technological advancements in the field of companion diagnostics

2 Key Market Indicators

Companion diagnostic test revenue and sales volume
Growth rate of oncology drugs that require companion diagnostics
Number of FDA and EMA approvals for oncology companion diagnostics
Percentage of oncology treatments using companion diagnostics
Pricing trends of companion diagnostics tests
Number of hospitals and laboratories providing companion diagnostic tests
R&D expenditure in the companion diagnostics industry

3 Growth Trends

Increase in precision oncology treatments leading to a rise in the use of companion diagnostics
Integration of next-generation sequencing in companion diagnostics for oncology
Growth in collaborations between pharmaceutical companies and diagnostic companies
Emerging markets showing significant growth in the adoption of companion diagnostics
Increased usage of liquid biopsies in companion diagnostics
Advancements in bioinformatics leading to more efficient and accurate companion diagnostic test results
Growth in targeted therapies leading to the rising need for companion diagnostics in oncology

Secondary Research

Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Companion Diagnostics for Oncology Market. Key inputs include:

Company-Level Information

Annual reports, investor presentations, SEC filings
Company press releases and product launch announcements
Public executive interviews and earnings calls
Strategy briefings and M&A updates

Industry and Government Sources

Country-level industry associations and trade bodies
Government dossiers, policy frameworks, and official releases
Whitepapers, working papers, and public R&D initiatives
Relevant Associations for the Companion Diagnostics for Oncology Market

Market Intelligence Sources

Broker reports and financial analyst coverage
Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
Import/export trade data and tariff databases
Sector-specific journals, magazines, and news portals

Macro & Consumer Insights

Global macroeconomic indicators and their cascading effect on the industry
Demand–supply outlook and value chain analysis
Consumer behaviour, adoption rates, and commercialization trends

Primary Research

To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:

Expert Insights & KOL Engagements

Key Opinion Leader (KOL) Engagements
Structured interviews with executives, product managers, and domain experts
Paid and barter-based interviews across manufacturers, distributors, and end-users

Focused Discussions & Panels

Discussions with stakeholders to validate demand-supply gaps
Group discussions on emerging technologies, regulatory shifts, and adoption barriers

Data Validation & Business POV

Cross-verification of market sizing and forecasts with industry insiders
Capturing business perspectives on growth opportunities and restraints

Data Triangulation & Forecasting

The final step of our research involves data triangulation ensuring accuracy through cross-verification of:

Demand-side analysis (consumption patterns, adoption trends, customer spending)
Supply-side analysis (production, capacity, distribution, and market availability)
Macroeconomic & microeconomic impact factors

Forecasting is carried out using proprietary models that combine: